| Literature DB >> 24587079 |
Martina Forlani1, Monica Morri1, Martino Belvederi Murri2, Virginia Bernabei1, Francesca Moretti1, Tobias Attili1, Anna Biondini1, Diana De Ronchi1, Anna Rita Atti1.
Abstract
OBJECTIVE: Anxiety among community-dwelling older adults has not been studied sufficiently. The aims of this cross-sectional population-based study were to estimate the point prevalence of clinically relevant anxiety symptoms and to describe their socio-demographic and clinical features, with particular focus on the association with somatic illnesses.Entities:
Mesh:
Year: 2014 PMID: 24587079 PMCID: PMC3935948 DOI: 10.1371/journal.pone.0089859
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Socio-demographic and clinical characteristics of the sample and subjects with anxiety symptoms.
| Sample | Anxiety symptoms | Test Value, df, | ||||
| N = 366 | NO (N = 289) | YES (N = 77) | ||||
|
| Males |
| 182 (49.7) | 154 (53.3) | 28 (36.4) |
|
|
|
| 83.7 (±6.2) | 84 (±6.4) | 82.4 (±5.4) | t = 1.939, df = 364, | |
|
| ≤80 y |
| 136 (37.1) | 104 (36.0) | 32 (41.5) |
|
| 81–85 y |
| 95 (26.0) | 74 (25.6) | 21 (27.3) | ||
| 86–90 y |
| 66 (18.0) | 48 (16.6) | 18 (23.4) | ||
| ≥91 y |
| 69 (18.9) | 63 (21.8) | 6 (7.8) | ||
|
| <5 y |
| 144 (39.3) | 115 (40.1) | 29 (37.7) |
|
| ≥5 y |
| 220 (60.7) | 172 (59.9) | 48 (62.3) | ||
|
|
| 26.4 (±3.7) | 26.4 (±3.7) | 26.4 (±3.8) | t = 0.099, df = 364, | |
|
|
| 78.7(±15.4) | 78.6(±15.5) | 79.5(±14.9) | t = −0.482, df = 352, | |
|
| Never married |
| 22 (6.1) | 17 (5.9) | 5 (6.8) |
|
| Married |
| 178 (49.4) | 137 (47.9) | 41 (55.4) | ||
| No longer married |
| 160 (44.5) | 132 (46.2) | 28 (37.8) | ||
|
| Low |
| 38 (10.5) | 25 (8.7) | 13 (16.9) |
|
| Medium |
| 319 (87.9) | 257 (89.9) | 62 (80.5) | ||
| High |
| 6 (1.6) | 4 (1.4) | 2 (2.6) | ||
|
| No |
| 273 (74.8) | 238 (82.4) | 35 (46.0) |
|
| Mild |
| 60 (16.4) | 35 (12.1) | 25 (32.9) | ||
| Moderate-Severe |
| 32 (8.8) | 16 (5.5) | 16 (21.1) | ||
|
| None |
| 63 (17.4) | 57 (19.8) | 6 (7.9) |
|
| 1 |
| 156 (43) | 119 (41.5) | 37 (48.7) | ||
| 2 |
| 108 (29.7) | 86 (30.0) | 22 (28.9) | ||
| ≥3 |
| 36 (9.9) | 25 (8.7) | 11 (14.5) | ||
|
| <1 |
| 150 (41.1) | 114 (39.6) | 36 (46.7) |
|
| 1 |
| 106 (29.0) | 93 (32.3) | 13 (16.9) | ||
| 2 |
| 88 (24.1) | 67 (23.3) | 21 (27.3) | ||
| >2 |
| 21 (5.8) | 14 (4.8) | 7 (9.1) | ||
*Comparison between persons with and without anxiety symptoms; X = Pearson Chi-square test, t = Student’s t test for independent samples, df = degree of freedom; MMSE (Mini Mental State Examination); CAM-Cog (Cambridge Cognitive Examination); SSE (Socio-economic status). Missing data αN = 2; βN = 6; γN = 3; δN = 1; φN = 3.
Figure 1Absolute number of subjects with overlapping anxiety symptoms, depression and physical morbidity.
As showed in the figure, anxiety symptoms co-occur with depression and physical morbidity in 25 older adults, 43,1% of the group with anxiety. Physical diseases are associated with anxiety symptoms in 29 subjects and with depression in 28 subjects. Anxiety symptoms were defined by the Geriatric Anxiety Inventory short form, using a cut-off score of three or more; depression was diagnosed according to ICD 10 Criteria; physical morbidity was defined as having at least one physical disease among anemia, diabetes, hypertension, coronary heart disease (CHD), cerebrovascular diseases, Parkinson’s Disease. Subjects with missing data for anxiety symptoms or depression or physical morbidity were excluded, leaving a total of 278 subjects.
Odds Ratios (OR) and 95% Confidence Intervals (95% CI) for anxiety symptoms in relation to female gender, age, physical morbidity, depression and alcohol consumption, estimated by multivariate logistic regression analyses.
| Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | |||||||
| OR (CI 95%) |
| OR (CI 95%) |
| OR (CI 95%) |
| OR (CI 95%) |
| OR (CI 95%) |
| ||
|
| Female | 1.937(1.142–3.285) | 0.014 | 2.302 (1.338–3.961) | 0.003 | 2.282 (1.315–3.960) | 0.003 | 2.440 (1.352–4.404) | 0.003 | 2.818 (1.439–5.519) | 0.003 |
|
| ≤80 y | − | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | |||||
| 81–85 y | − | − | 0.937 (0.492–1.785) | 0.843 | 0.876 (0.455–1.687) | 0.693 | 0.772 (0.382–1.562) | 0.472 | 0.801 (0.392–1.634) | 0.542 | |
| 86–90 y | − | − | 1.144 (0.568–2.304) | 0.707 | 1.043 (0.511–2.128) | 0.909 | 1.055 (0.488–2.278) | 0.892 | 1.229 (0.554–2.725) | 0.612 | |
| ≥91 y | − | − | 0.254 (0.098–0.658) | 0.005 | 0.257 (0.098–0.677) | 0.006 | 0.338 (0.124–0.923) | 0.034 | 0.373 (0.133–1.047) | 0.055 | |
|
| None | − | − | − | − | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | |||
| 1 | − | − | − | − | 2.579 (1.007–6.602) | 0.048 | 2.487 (0.923–6.697) | 0.072 | 2.281 (0.823–6.319) | 0.113 | |
| 2 | − | − | − | − | 2.526 (0.939–6.792) | 0.066 | 2.840 (0.995–8.108) | 0.051 | 2.494 (0.849–67.327) | 0.096 | |
| ≥3 | − | − | − | − | 3.627 (1.170–11.243) | 0.026 | 3.711 (1.119–12.305) | 0.032 | 3.525 (1.041–11.934) | 0.043 | |
|
| No | − | − | − | − | − | − | 1 (Ref.) | 1 (Ref.) | ||
| Mild | − | − | − | − | − | − | 4.813 (2.469–9.380) | <0.001 | 4.832 (2.456–9.508) | <0.001 | |
| Moderate-Severe | − | − | − | − | − | − | 7.164 (3.098–16.563) | <0.001 | 7.283 (3.087–17.182) | <0.001 | |
|
| 1 | − | − | − | − | − | − | − | − | 1 (Ref.) | |
| <1 | − | − | − | − | − | − | − | − | 1.908 (0.866–4.205) | 0.109 | |
| 2 | − | − | − | − | − | − | − | − | 2.483 (1.030–5.988) | 0.043 | |
| >2 | − | − | − | − | − | − | − | − | 4.242 (1.189–15.142) | 0.026 | |
Subjects with missing value for at least one variable were excluded, leaving 355 subjects for each model.
Model 1, gender; Model 2, gender and age; Model 3, gender, age and physical morbidity; Model 4, gender, age, physical morbidity and depression;
Model 5, gender, age, physical morbidity, depression and alcohol consumption.